Buscas alternativas:
decrease statins » disease statins (Expandir a busca)
costs processing » cost processing (Expandir a busca), post processing (Expandir a busca), codas processing (Expandir a busca)
statins increase » statins decrease (Expandir a busca), strains increases (Expandir a busca), status increases (Expandir a busca)
decrease costs » decreasing costs (Expandir a busca), decreases post (Expandir a busca), disease costs (Expandir a busca)
decrease il » decreased il (Expandir a busca), decrease in (Expandir a busca), decrease hiv (Expandir a busca)
il decrease » l decrease (Expandir a busca), will decrease (Expandir a busca), oil decreases (Expandir a busca)
of decrease » or decrease (Expandir a busca), not decrease (Expandir a busca), to decrease (Expandir a busca)
decrease statins » disease statins (Expandir a busca)
costs processing » cost processing (Expandir a busca), post processing (Expandir a busca), codas processing (Expandir a busca)
statins increase » statins decrease (Expandir a busca), strains increases (Expandir a busca), status increases (Expandir a busca)
decrease costs » decreasing costs (Expandir a busca), decreases post (Expandir a busca), disease costs (Expandir a busca)
decrease il » decreased il (Expandir a busca), decrease in (Expandir a busca), decrease hiv (Expandir a busca)
il decrease » l decrease (Expandir a busca), will decrease (Expandir a busca), oil decreases (Expandir a busca)
of decrease » or decrease (Expandir a busca), not decrease (Expandir a busca), to decrease (Expandir a busca)
1
2
COMPARATIVE ANALYSIS OF THE USE OF STATINS AND NICOTINIC ACID IN THE TREATMENT OF METABOLIC SYNDROME
Assuntos:
“...Metabolic syndrome, Statins, Nicotinic acid...”Acessar documento
Artigo
3
4
“... (n = 132, 25 sarcopenic), the use of statins was inversely associated with sarcopenia (OR = 0.03...”
Acessar documento
Acessar documento
Artigo
5
“...) cholesterol, apolipoprotein (Apo) B, and triglycerides and to increase levels of high-density lipoprotein (HDL...”
Acessar documento
Acessar documento
Artigo
6
7
8
9
10
11
12
“... for the majority of the production costs of biopharmaceuticals (50–90%) [3]. The downstream processing...”
Acessar documento
Acessar documento
13
14
15
16
17
18
19
20
“...Background: Dyslipidemia is the primary risk factor for cardiovascular disease, and statins have...”
Acessar documento
Acessar documento
Artigo